Atamyo Therapeutics
France · EIC Accelerator March 2024
Not yet checkedRasph has not investigated this company yet
- ATA-10013 March 2024 cut-off
Smart, organotropic gene therapy designed for optimised efficacy, patient safety and affordability to treat limb-girdle muscular dystrophy-R9
Blended finance
Website: atamyo.com